Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 24;2(1):100181.
doi: 10.1016/j.inpm.2023.100181. eCollection 2023 Mar.

Virtual reality therapy for myofascial pain: Evolving towards an evidence-based non-pharmacologic adjuvant intervention

Erik F Wang  1 , Rohan Jotwani  2
Affiliations

Virtual reality therapy for myofascial pain: Evolving towards an evidence-based non-pharmacologic adjuvant intervention

Erik F Wang et al. Interv Pain Med. .

Abstract

Myofascial pain syndrome (MPS) is a highly prevalent and burdensome cause of pain globally, representing a major focus of chronic pain management. Management of MPS is highly variable, with therapies ranging from interventional approaches to physical therapy. Virtual reality (VR) is a novel form of therapy being actively explored as an adjuvant to procedural sedation in the acute pain setting, and increasingly as a means of chronic pain management through programs that facilitate pain education, physical therapy and mindfulness, among other approaches. However, to date, there are minimal clinical studies assessing VR therapy within the context of MPS treatments. Given the existing volume of work published in the acute pain setting and the translational work exploring VR and neuroplasticity in chronic pain, we make the case here that it is an appropriate time to consider exploring VR therapy as a non-pharmacological adjuvant treatment for MPS.

Keywords: Digital therapeutics; Extended reality; Myofascial pain syndrome; Trigger point injections; Virtual reality.

PubMed Disclaimer

Conflict of interest statement

Rohan Jotwani is a Scientific Advisor to Medis Media, but he owns no shares/financial interests with the organization and receives no funding from the organization. Erik Wang has no conflicts of interest to report.

Similar articles

See all similar articles

References

    1. Borg-Stein J., Iaccarino M.A. Myofascial pain syndrome treatments. Phys Med Rehabil Clin. 2014 May;25(2):357–374. doi: 10.1016/j.pmr.2014.01.012. Epub 2014 Mar 17. PMID: 24787338. - DOI - PubMed
    1. Fleckenstein J., Zaps D., Rüger L.J., Lehmeyer L., Freiberg F., Lang P.M., Irnich D. Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: results of a cross-sectional, nationwide survey. BMC Muscoskel Disord. 2010 Feb 11;11:32. doi: 10.1186/1471-2474-11-32. PMID: 20149248; PMCID: PMC2836281. - DOI - PMC - PubMed
    1. Srbely J.Z. New trends in the treatment and management of myofascial pain syndrome. Curr Pain Headache Rep. 2010 Oct;14(5):346–352. doi: 10.1007/s11916-010-0128-4. PMID: 20607458. - DOI - PubMed
    1. Giamberardino M.A., Affaitati G., Fabrizio A., Costantini R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol. 2011 Apr;25(2):185–198. doi: 10.1016/j.berh.2011.01.002. PMID: 22094195. - DOI - PubMed
    1. Podichetty V.K., Mazanec D.J., Biscup R.S. Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention. Postgrad Med. 2003 Nov;79(937):627–633. doi: 10.1136/pmj.79.937.627. PMID: 14654573; PMCID: PMC1742882. - DOI - PMC - PubMed

LinkOut - more resources